An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU. Indian J Child Health [Internet]. 2021 Dec. 28 [cited 2024 Nov. 22];8(12):404-7. Available from: https://mansapublishers.com/index.php/ijch/article/view/3213